Session Details

Workshop 6 - CAR-T Racing: Amateurs & Rookies Looking to Contribute
Saturday, September 14, 2019 03:45 PM - 05:15 PM
Plenary Hall
This session will include 3 speakers who each provide unique experiences bringing CAR T cells to patients at their institution. The session will include examples of programs that have cellular therapy experience but only utilize CAR T from other experienced centers, large programs that support many CAR T programs, as well as a program that has developed their own CAR T program from scratch. Each speaker will cover various aspects of implementing the CAR T cells, including chain of custody, labeling, and product receipt and storage.


Patrick Hanley, PhD Children’s National Health System, USA


Trial and Tribulations: Lessons Learned when preparing for an Industry-Sponsored Clinical Study
Lizette Caballero, BS, MT(ASCP), UCSF Blood and Marrow Transplant Lab, USA
Learning objectives:
•      Discuss the challenges of addressing discrepancies between sponsor’s procedure and in-house procedure, existing labelling system with sponsor’s requirements.
•      Describe best approaches to standardization of testing and SOPs between the different industry-sponsored clinical studies.
•      Share strategies use for staff training.

DIY – CAR T cells: Flipping Your Cell Therapy Lab
Paul Eldridge, PhD, UNC Lineberger Comprehensive Cancer Center, USA
Learning objectives:
•      Provide overview of critical components for on-site CAR T cell manufacturing.
•      Review of example process/product development timeline.
•      Discussion of academic/corporate partnership models.

Drive the change: Bringing CAR-T therapies to your institution
Hema Dave, Md, MPH, Children’s National Medical Center, USA
Learning objectives:
•      Provide an overview of commercially approved CAR therapies for leukemia and lymphoma
•      To understand the building blocks to implement CART therapies
•      Rolling out the CART program with available resources